Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by D Corscadden
High Serum B Cell Activating Factor Predicts Good Clinical Response to Rituximab in RA: Pilot Data
Annals of the Rheumatic Diseases
Immunology
Molecular Biology
Biochemistry
Rheumatology
Allergy
Genetics
Related publications
Effect of Rituximab on B Cell Phenotype and Serum B Cell-Activating Factor Levels in Patients With Thrombotic Thrombocytopenic Purpura
Clinical and Experimental Immunology
Allergy
Immunology
Response to Steroids Predicts Response to Rituximab in Pediatric Chronic Immune Thrombocytopenia.
Blood
Biochemistry
Immunology
Cell Biology
Hematology
Response to Steroids Predicts Response to Rituximab in Pediatric Chronic Immune Thrombocytopenia
Pediatric Blood and Cancer
Oncology
Child Health
Hematology
Perinatology
Medicine
Pediatrics
Neutralization of (NK-cell-derived) B-Cell Activating Factor by Belimumab Restores Sensitivity of Chronic Lymphoid Leukemia Cells to Direct and Rituximab-Induced NK Lysis
Leukemia
Cancer Research
Oncology
Anesthesiology
Pain Medicine
Hematology
GPIIb/IIIa Autoantibody Predicts Better Rituximab Response in ITP
British Journal of Haematology
Hematology
B Cell Activating Factor (BAFF) Induces the Transcription of Recombination-Activating Genes in Transitional Stage 1 B Cells
Central-European Journal of Immunology
Allergy
Immunology
Pretreatment Serum HBsAg-to-HBV DNA Ratio Predicts a Virologic Response to Entecavir in Chronic Hepatitis B
The Korean Journal of Hepatology
Serum Vascular Endothelial Growth Factor and Fibronectin Predict Clinical Response to High-Dose Interleukin-2 Therapy
Journal of Clinical Oncology
Cancer Research
Medicine
Oncology
TLR4 Promotes B Cell Maturation: Independence and Cooperation With B Lymphocyte-Activating Factor
Journal of Immunology
Allergy
Immunology
